Investor Presentaiton slide image

Investor Presentaiton

Internal R&D strengths are amplified through extensive network of external partnerships SevenBridges biobank TEMPUS COTA PicnicHealth Memorial Sloan Kettering Cancer Center editas Genes & Health strandiji TWIST ENVISAGENICS -ArsenalBio Guardian RESEARCH NETWORK 1-O International Immuno-Oncology Network indivumed Concert Al GNS HEALTHCARE CENTURY THERAPEUTICS Fred Hutch Cancer Center Peter Mac Peter MacCallum Cancer Centre Victoria Australia Eisai →volastra ---- MEDIC Immatics 药明巨诺 B A-ALPHA BIO SGC CHARM THERAPEUTICS flatiron FINNGEN CROHN'S &COLITIS FOUNDATION NEW YORK GENOME CENTER HITGEN Scripps Research ADNI A AVIDITY BIOSCIENCES insitro AMPHISTA THERAPEUTICS prothena DARWIN HEALTH evotec 熊本大学 EMORY PRECISION THERAPEUTICS for CANCER MEDICINE Kumamoto University UNIVERSITY REPARE THERAPEUTICS SyntheX PathAl UNIVERSITY OF OXFC gentibio NORDIC BIOSCIENCE Roche santaris pharma a/s Fulcrum Therapeutics Logon OCTANT IMIDomics Agilent BD Adaptive BIOCARTIS illumina Thermo Fisher SCIENTIFIC HEMATOGENIX UNIVERSITY OF MIAMI Queen Mary University of London somalogic MAYO CLINIC МРААСТ THE ROYAL MARSDEN biopôle Open Targets Exscientia KeyBioscience SKYHAWK evotec THERAPEUTICE TUBULIS SCHRÖDINGER. Incentive Molecular Halozyme beLAB2122 LAB282 Templates JW Therapeutics Neuroscience Cardiovascular Protein Degradation Immunology Oncology & Hematology Computational Biology Small Molecule Drug Discovery Ill Bristol Myers Squibb™ Illi Bristol Myers Squibb™ > 100 active strategic collaborations BMS also has an extensive network of over 150 academic research alliances Translational Medicine DxTerity beLAB1407 JOHNS HOPKINS UNIVERSITY Cross- Therapeutic Mount Sinai Penn COLUMBIA UNIVERSITY Discovery Biotherapeutics X CYTOMX THERAPEUTICS zymeworks RECOMBINANT ANTIBODY NETWORK Adimab Not for Product Promotional Use 49
View entire presentation